ZOSANO PHARMA CORPORATION 34790 Ardentech Court Fremont,California 94555
Exhibit 10.43
ZOSANO PHARMA CORPORATION
34790 Ardentech Court
Fremont, California 94555
[date]
LADENBURG THALMANN & CO. INC.
570 Lexington Avenue, 11th Floor
New York, NY 10022
ROTH CAPITAL PARTNERS, LLC
888 San Clemente Drive
Newport Beach, CA 92660
Re: Private | Placement Fee |
Ladies and Gentlemen:
In order to induce Ladenburg Thalmann & Co. Inc. (Ladenburg) and Roth Capital Partners, LLC (Roth and, together with Ladenburg, the Managers) to act as the joint book-running managers and representatives of the underwriters for the proposed initial public offering of common stock (the IPO) of Zosano Pharma Corporation (the Company), the Company hereby agrees to pay the Managers a fee (the Private Placement Fee) equal in the aggregate to 3.5% of the gross proceeds received by the Company from the sale of shares of common stock of the Company to Eli Lilly and Company, or any of its affiliates (Lilly), pursuant to that certain Common Stock Purchase Agreement, dated as of November 21, 2014, by and between the Company and Lilly, pursuant to which Lilly has agreed to purchase up to $15 million of the Companys shares of common stock (the Private Placement). The Private Placement Fee will be divided equally between the Managers and paid immediately upon receipt by the Company of any proceeds of the Private Placement.
Sincerely yours, | ||
Zosano Pharma Corporation | ||
By: | Vikram Lamba | |
Title: | Chief Executive Officer |